3851 - 3900 of 6570 Results
Title
Year
-
OPENTitle: Transgene expression in the striatum following intracerebral injections of DNA nanoparticles encoding for human glial cell line-derived neurotrophic factorJournal Name: NeurosciencePublisher: Elsevier BVVol: 194Issue #:Start Page: 220End Page: 226Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.neuroscience.2011.07.072Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/3408714Citation Count: 34
-
OPENTitle: Single-Cell Phenotyping within Transparent Intact Tissue through Whole-Body ClearingJournal Name: CellPublisher: Elsevier BVVol: 158Issue #: 4Start Page: 945End Page: 958Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.cell.2014.07.017Best OA location URL: http://www.cell.com/article/S0092867414009313/pdfCitation Count: 974
-
OPENTitle: Bioactive Flavonoids and Catechols as Hif1 and Nrf2 Protein Stabilizers - Implications for Parkinson’s DiseaseJournal Name: Aging and diseasePublisher: Aging and DiseaseVol: 7Issue #: 6Start Page: 745End Page: 745Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.14336/ad.2016.0505Best OA location URL: http://www.aginganddisease.org/EN/article/downloadArticleFile.do?attachType=PDF&id=147551Citation Count: 25
-
OPENTitle: Characterization of fibromyalgia symptoms in patients 55–95 years old: a longitudinal study showing symptom persistence with suboptimal treatmentJournal Name: Aging Clinical and Experimental ResearchPublisher: Springer Science and Business Media LLCVol: 27Issue #: 1Start Page: 75End Page: 82Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1007/s40520-014-0238-7Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/4244273Citation Count: 36
-
OPENTitle: Transgenic mice expressing S129 phosphorylation mutations in α-synucleinJournal Name: Neuroscience LettersPublisher: Elsevier BVVol: 563Issue #:Start Page: 96End Page: 100Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.neulet.2014.01.033Best OA location URL: http://doi.org/10.1016/j.neulet.2014.01.033Citation Count: 15
-
OPENTitle: Correlation of Clinical Features With Argyrophilic Grains at AutopsyJournal Name: Alzheimer Disease & Associated DisordersPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 23Issue #: 3Start Page: 229End Page: 233Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1097/wad.0b013e318199d833Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/2760041Citation Count: 61
-
OPENTitle: Low-dose Lithium Treatment for Agitation and Psychosis in Alzheimer Disease and Frontotemporal DementiaJournal Name: Alzheimer Disease & Associated DisordersPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 31Issue #: 1Start Page: 73End Page: 75Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1097/wad.0000000000000161Best OA location URL: http://doi.org/10.1097/WAD.0000000000000161Citation Count: 72
-
OPENTitle: A role for a novel protein, nucleolin, in Parkinson's diseaseJournal Name: Neuroscience LettersPublisher: Elsevier BVVol: 459Issue #: 1Start Page: 11End Page: 15Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.neulet.2009.04.060Best OA location URL: http://doi.org/10.1016/j.neulet.2009.04.060Citation Count: 48
-
OPENTitle: Mild cognitive impairment in Parkinson's disease versus Alzheimer's diseaseJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 27Issue #:Start Page: 54End Page: 60Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2016.04.007Best OA location URL: http://doi.org/10.1016/j.parkreldis.2016.04.007Citation Count: 30
-
OPENTitle: Sleep Duration and “on” Time during Different Periods of the Day and Night in Patients with Advanced Parkinson's Disease Receiving Adjunctive Ropinirole Prolonged ReleaseJournal Name: Parkinson's DiseasePublisher: WileyVol: 2011Issue #:Start Page: 1End Page: 8Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.4061/2011/354760Best OA location URL: https://downloads.hindawi.com/journals/pd/2011/354760.pdfCitation Count: 15
-
OPENTitle: Markers of impaired motor and cognitive volition in Parkinson's disease: Correlates of dopamine dysregulation syndrome, impulse control disorder, and dyskinesiasJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 47Issue #:Start Page: 50End Page: 56Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2017.11.338Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/5803355Citation Count: 21
-
OPENTitle: Models for LRRK2-Linked ParkinsonismJournal Name: Parkinson's DiseasePublisher: WileyVol: 2011Issue #:Start Page: 1End Page: 16Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.4061/2011/942412Best OA location URL: https://downloads.hindawi.com/journals/pd/2011/942412.pdfCitation Count: 34
-
OPENTitle: Effect of Deep Brain Stimulation on Parkinson's Nonmotor Symptoms following Unilateral DBS: A Pilot StudyJournal Name: Parkinson's DiseasePublisher: WileyVol: 2011Issue #:Start Page: 1End Page: 4Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.4061/2011/507416Best OA location URL: https://downloads.hindawi.com/journals/pd/2011/507416.pdfCitation Count: 29
-
OPENTitle: Sex disparities in health and health care utilization after Parkinson diagnosis: Rethinking PD associated disabilityJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 48Issue #:Start Page: 45End Page: 50Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2017.12.012Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/6559800Citation Count: 32
-
OPENTitle: The Current State and Needs of North American Movement Disorders Fellowship ProgramsJournal Name: Parkinson's DiseasePublisher: WileyVol: 2013Issue #:Start Page: 1End Page: 7Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1155/2013/701426Best OA location URL: https://downloads.hindawi.com/journals/pd/2013/701426.pdfCitation Count: 10
-
OPENTitle: The Anticholinesterase Phenserine and Its Enantiomer Posiphen as 5′Untranslated-Region-Directed Translation Blockers of the Parkinson’s Alpha Synuclein ExpressionJournal Name: Parkinson's DiseasePublisher: WileyVol: 2012Issue #:Start Page: 1End Page: 13Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1155/2012/142372Best OA location URL: https://downloads.hindawi.com/journals/pd/2012/142372.pdfCitation Count: 57
-
OPENTitle: Juvenile onset Parkinsonism with “pure nigral” degeneration and POLG1 mutationJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 30Issue #:Start Page: 83End Page: 85Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2016.06.013Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/5995126Citation Count: 14
-
OPENTitle: Health comorbidities and cognition in 1948 patients with idiopathic Parkinson's diseaseJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 18Issue #: 10Start Page: 1073End Page: 1078Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2012.06.004Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/6545886Citation Count: 35
-
OPENTitle: Do Somatic Mitochondrial DNA Mutations Contribute to Parkinson's Disease?Journal Name: Parkinson's DiseasePublisher: WileyVol: 2011Issue #:Start Page: 1End Page: 9Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.4061/2011/659694Best OA location URL: https://downloads.hindawi.com/journals/pd/2011/659694.pdfCitation Count: 16
-
OPENTitle: Web-Based Genome-Wide Association Study Identifies Two Novel Loci and a Substantial Genetic Component for Parkinson's DiseaseJournal Name: PLoS GeneticsPublisher: Public Library of Science (PLoS)Vol: 7Issue #: 6Start Page: e1002141End Page: e1002141Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1371/journal.pgen.1002141Best OA location URL: https://escholarship.org/uc/item/1zw763wgCitation Count: 534
-
OPENTitle: A Link between Autophagy and the Pathophysiology of LRRK2 in Parkinson's DiseaseJournal Name: Parkinson's DiseasePublisher: Hindawi LimitedVol: 2012Issue #:Start Page: 1End Page: 9Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1155/2012/324521Best OA location URL: https://downloads.hindawi.com/journals/pd/2012/324521.pdfCitation Count: 28
-
OPENTitle: The Penn Parkinson's Daily Activities Questionnaire-15: Psychometric properties of a brief assessment of cognitive instrumental activities of daily living in Parkinson's diseaseJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 25Issue #:Start Page: 21End Page: 26Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2016.02.020Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/4818172Citation Count: 74
-
OPENTitle: Mitochondrial therapies for Parkinson's diseaseJournal Name: Movement DisordersPublisher: WileyVol: 25Issue #: S1Start Page: S155End Page: 60Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.22781Best OA location URL: http://doi.org/10.1002/mds.22781Citation Count: 62
- Lowering the risk of Parkinson’s disease with GLP-1 agonists and DPP4 inhibitors in type 2 diabetes2020OPENTitle: Lowering the risk of Parkinson’s disease with GLP-1 agonists and DPP4 inhibitors in type 2 diabetesJournal Name: BrainPublisher: Oxford University Press (OUP)Vol: 143Issue #: 10Start Page: 2868End Page: 2871Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1093/brain/awaa287Best OA location URL: https://academic.oup.com/brain/article-pdf/143/10/2868/34032411/awaa287.pdfCitation Count: 14
-
OPENTitle: Feedforward activation of PRKN/parkinJournal Name: AutophagyPublisher: Informa UK LimitedVol: 19Issue #: 2Start Page: 729End Page: 730Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1080/15548627.2022.2100615Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/9851250Citation Count: 9
-
OPENTitle: Pathogenic Mechanisms of Cytosolic and Membrane-Enriched α-Synuclein Converge on Fatty Acid HomeostasisJournal Name: The Journal of NeurosciencePublisher: Society for NeuroscienceVol: 42Issue #: 10Start Page: 2116End Page: 2130Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-saDOI - Digital Object Identifier: 10.1523/jneurosci.1881-21.2022Best OA location URL: https://www.jneurosci.org/content/jneuro/42/10/2116.full.pdfCitation Count: 26
-
OPENTitle: Nanomicellar formulation of coenzyme Q10 (Ubisol-Q10) effectively blocks ongoing neurodegeneration in the mouse 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model: potential use as an adjuvant treatment in Parkinson's diseaseJournal Name: Neurobiology of AgingPublisher: Elsevier BVVol: 35Issue #: 10Start Page: 2329End Page: 2346Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.neurobiolaging.2014.03.032Best OA location URL: http://doi.org/10.1016/j.neurobiolaging.2014.03.032Citation Count: 70
-
OPENTitle: Understanding the Neurobiology of Cd200 and the Cd200 Receptor: A Therapeutic Target For Controlling Inflammation In Human Brains?Journal Name: Future NeurologyPublisher: Informa UK LimitedVol: 8Issue #: 3Start Page: 321End Page: 332Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.2217/fnl.13.14Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/3815586Citation Count: 54
-
OPENTitle: Parkinson's disease prevalence in Fabry disease: A survey studyJournal Name: Molecular Genetics and Metabolism ReportsPublisher: Elsevier BVVol: 14Issue #:Start Page: 27End Page: 30Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.ymgmr.2017.10.013Best OA location URL: https://doi.org/10.1016/j.ymgmr.2017.10.013Citation Count: 39
-
OPENTitle: A harmonized segmentation protocol for hippocampal and parahippocampal subregions: Why do we need one and what are the key goals?Journal Name: HippocampusPublisher: WileyVol: 27Issue #: 1Start Page: 3End Page: 11Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/hipo.22671Best OA location URL: https://archive-ouverte.unige.ch/unige:111733Citation Count: 181
-
OPENTitle: Neuroimmunology of the Interleukins 13 and 4Journal Name: Brain SciencesPublisher: MDPI AGVol: 6Issue #: 2Start Page: 18End Page: 18Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3390/brainsci6020018Best OA location URL: https://www.mdpi.com/2076-3425/6/2/18/pdf?version=1465804812Citation Count: 126
-
OPENTitle: DAT-SPECT-based subtype and stage inference in Parkinson’s diseaseJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 12Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-026-01347-2Best OA location URL: https://www.nature.com/articles/s41531-026-01347-2_reference.pdfCitation Count: 1
-
OPENTitle: MAPT H1 haplotype is a risk factor for essential tremor and multiple system atrophyJournal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 76Issue #: 7Start Page: 670End Page: 672Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1212/wnl.0b013e31820c30c1Best OA location URL: http://n.neurology.org/content/neurology/76/7/670.full.pdfCitation Count: 75
- Reduced uptake of [ 18 F]FDOPA PET in asymptomatic welders with occupational manganese exposure2011OPENTitle: Reduced uptake of [ 18 F]FDOPA PET in asymptomatic welders with occupational manganese exposureJournal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 76Issue #: 15Start Page: 1296End Page: 1301Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1212/wnl.0b013e3182152830Best OA location URL: https://n.neurology.org/content/neurology/76/15/1296.full.pdfCitation Count: 84
-
OPENTitle: Quantitative EEG as a predictive biomarker for Parkinson disease dementiaJournal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 77Issue #: 2Start Page: 118End Page: 124Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1212/wnl.0b013e318224af8dBest OA location URL: https://n.neurology.org/content/neurology/77/2/118.full.pdfCitation Count: 211
-
OPENTitle: Olfactory dysfunction in LRRK2 G2019S mutation carriersJournal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 77Issue #: 4Start Page: 319End Page: 324Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1212/wnl.0b013e318227041cBest OA location URL: https://n.neurology.org/content/neurology/77/4/319.full.pdfCitation Count: 62
-
OPENTitle: Methylphenidate for gait impairment in Parkinson diseaseJournal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 76Issue #: 14Start Page: 1256End Page: 1262Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1212/wnl.0b013e3182143537Best OA location URL: https://n.neurology.org/content/neurology/76/14/1256.full.pdfCitation Count: 93
-
OPENTitle: Placebo effect of medication cost in Parkinson diseaseJournal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 84Issue #: 8Start Page: 794End Page: 802Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1212/wnl.0000000000001282Best OA location URL: https://n.neurology.org/content/neurology/84/8/794.full.pdfCitation Count: 141
-
OPENTitle: SAMTOR is an S -adenosylmethionine sensor for the mTORC1 pathwayJournal Name: SciencePublisher: American Association for the Advancement of Science (AAAS)Vol: 358Issue #: 6364Start Page: 813End Page: 818Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1126/science.aao3265Best OA location URL: https://science.sciencemag.org/content/sci/358/6364/813.full.pdfCitation Count: 544
-
OPENTitle: When DLB, PD, and PSP masquerade as MSAJournal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 85Issue #: 5Start Page: 404End Page: 412Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1212/wnl.0000000000001807Best OA location URL: https://n.neurology.org/content/neurology/85/5/404.full.pdfCitation Count: 351
-
OPENTitle: Prospective cohort study of spinal muscular atrophy types 2 and 3Journal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 79Issue #: 18Start Page: 1889End Page: 1897Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1212/wnl.0b013e318271f7e4Best OA location URL: https://n.neurology.org/content/neurology/79/18/1889.full.pdfCitation Count: 291
-
OPENTitle: Safety/feasibility of targeting the substantia nigra with AAV2-neurturin in Parkinson patientsJournal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 80Issue #: 18Start Page: 1698End Page: 1701Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1212/wnl.0b013e3182904faaBest OA location URL: https://n.neurology.org/content/neurology/80/18/1698.full.pdfCitation Count: 213
-
OPENTitle: mzStudio: A Dynamic Digital Canvas for User-Driven Interrogation of Mass Spectrometry DataJournal Name: ProteomesPublisher: MDPI AGVol: 5Issue #: 3Start Page: 20End Page: 20Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3390/proteomes5030020Best OA location URL: https://www.mdpi.com/2227-7382/5/3/20/pdf?version=1501590909Citation Count: 26
-
OPENTitle: Imaging prodromal Parkinson diseaseJournal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 83Issue #: 19Start Page: 1739End Page: 1746Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1212/wnl.0000000000000960Best OA location URL: https://n.neurology.org/content/neurology/83/19/1739.full.pdfCitation Count: 171
-
OPENTitle: Human whole genome genotype and transcriptome data for Alzheimer’s and other neurodegenerative diseasesJournal Name: Scientific DataPublisher: Springer Science and Business Media LLCVol: 3Issue #: 1Start Page: 160089End Page: 160089Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/sdata.2016.89Best OA location URL: https://www.nature.com/articles/sdata201689.pdfCitation Count: 533
- Identification of extracellular miRNA in human cerebrospinal fluid by next-generation sequencing2013OPENTitle: Identification of extracellular miRNA in human cerebrospinal fluid by next-generation sequencingJournal Name: RNAPublisher: Cold Spring Harbor LaboratoryVol: 19Issue #: 5Start Page: 712End Page: 722Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1261/rna.036863.112Best OA location URL: http://rnajournal.cshlp.org/content/19/5/712.full.pdfCitation Count: 189
-
OPENTitle: Maladaptive striatal plasticity in l-DOPA-induced dyskinesiaJournal Name: Progress in Brain ResearchPublisher: ElsevierVol:Issue #:Start Page: 209End Page: 233Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/s0079-6123(10)83011-0Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/2930606Citation Count: 215
-
OPENTitle: Physico-chemical determinants of soluble intrabody expression in mammalian cell cytoplasmJournal Name: Protein Engineering, Design and SelectionPublisher: Oxford University Press (OUP)Vol: 23Issue #: 6Start Page: 489End Page: 498Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1093/protein/gzq022Best OA location URL: https://academic.oup.com/peds/article-pdf/23/6/489/17494272/gzq022.pdfCitation Count: 63
-
OPENTitle: Why Do We Need Multifunctional Neuroprotective and Neurorestorative Drugs for Parkinson’s and Alzheimer’s Disorders?Journal Name: Rambam Maimonides Medical JournalPublisher: Rambam Health CorporationVol: 1Issue #: 2Start Page: e0011End Page: e0011Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.5041/rmmj.10011Best OA location URL: https://doi.org/10.5041/rmmj.10011Citation Count: 8
- Global quantitative analysis of the human brain proteome in Alzheimer’s and Parkinson’s Disease2018OPENTitle: Global quantitative analysis of the human brain proteome in Alzheimer’s and Parkinson’s DiseaseJournal Name: Scientific DataPublisher: Springer Science and Business Media LLCVol: 5Issue #: 1Start Page: 180036End Page: 180036Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/sdata.2018.36Best OA location URL: https://www.nature.com/articles/sdata201836.pdfCitation Count: 268